The Open Nanomedicine and Nanotechnology Journal


Formerly: The Open Nanomedicine Journal

ISSN: 2666-1500 ― Volume 6, 2019

Zinc Oxide Nanoparticles: Therapeutic Benefits and Toxicological Hazards



Said Said Elshama1, 2, Metwally E. Abdallah1, Rehab I. Abdel-Karim1, *
1 Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
2 College of Medicine, Taif University, Taif, Saudi Arabia.

Abstract

Despite the widespread application of zinc oxide nanoparticles in biomedicine, their use is still a controversial issue. Zinc oxide nanoparticles were reported to have therapeutic benefits. However, they were reported to have toxicological hazards as well. Several studies reported the antibacterial, anticancer, antioxidant, and immunomodulatory effects of zinc oxide nanoparticles. Additionally, zinc oxide nanoparticles were used in sunscreens. Furthermore, the ability to use zinc oxide nanoparticles as an adjuvant treatment to alleviate the toxic effects of chemotherapeutic drugs has been reported. However, zinc oxide nanoparticles were shown to induce toxic effects in different body organs and systems. The affected organs included liver, spleen, kidney, stomach, pancreas, heart and lung. In addition, zinc oxide nanoparticles were reported to adversely affect the neurological system, lymphatic system, hematological indices, sex hormones levels, and fetal development. The toxic effects of zinc oxide nanoparticles were based on their concentration, their dose, the route of their administration, and the time of exposure to those particles. Thus, it is crucial to assess their efficacy and safety to determine their toxicological risks and therapeutic benefits.

Keywords: Zinc oxide, Nanoparticles, Benefits, Hazards, Antibacterial, Anticancer.


Article Information


Identifiers and Pagination:

Year: 2018
Volume: 5
First Page: 16
Last Page: 22
Publisher Id: TONMJ-5-16
DOI: 10.2174/1875933501805010016

Article History:

Received Date: 4/5/2018
Revision Received Date: 12/6/2018
Acceptance Date: 26/6/2018
Electronic publication date: 19/7/2018
Collection year: 2018

Article Metrics:

CrossRef Citations:
0

Total Statistics:

Full-Text HTML Views: 4263
Abstract HTML Views: 1295
PDF Downloads: 603
ePub Downloads: 343
Total Views/Downloads: 6504

Unique Statistics:

Full-Text HTML Views: 1942
Abstract HTML Views: 753
PDF Downloads: 475
ePub Downloads: 237
Total Views/Downloads: 3407
Geographical View

© 2018 Elshama et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


* Address correspondence to this author at the Forensic Medicine & Clinical Toxicology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt; Tel: 00201007344788; E-mail: rehabnegm@yahoo.com





1. BACKGROUND

Nanoparticles may be natural or synthetic. Synthetic nanoparticles are classified into several types; such as metal nanoparticles (e.x. gold and silver nanoparticles), metal oxide nanoparticles (e.x. zinc oxide), carbon nanoparticles, and quantum dots (e.x. cadmium selenide). Synthetic nanoparticles have physicochemical features and special reactivity, which are attributed to their small size, and to their high surface area in comparison to their larger counterparts of the same material. In synthetic nanoparticles, the proportion of atoms on the surface is much larger than the proportion of atoms in the interior of the particle. These factors give synthetic nanoparticles a higher surface reactivity than their counterparts of the same material [1Handy RD, von der Kammer F, Lead JR, Hassellöv M, Owen R, Crane M. The ecotoxicology and chemistry of manufactured nanoparticles. Ecotoxicology 2008; 17(4): 287-314.
[http://dx.doi.org/10.1007/s10646-008-0199-8] [PMID: 18351458]
].

Zinc is a nutritional supplement and food additive. The melted and oxidized zinc at a high temperature can generate zinc oxide nanoparticles that affect the growth of many bacteria such as Staphylococcus, Streptococcus, and E. coli [2Kao YY, Chen YC, Cheng TJ, Chiung YM, Liu PS. Zinc oxide nanoparticles interfere with zinc ion homeostasis to cause cytotoxicity. Toxicol Sci 2012; 125(2): 462-72.
[http://dx.doi.org/10.1093/toxsci/kfr319] [PMID: 22112499]
]. Currently, there are widespread applications of zinc oxide nanoparticles in medicine because of their antibacterial effect. They are also used in several industries such as paints, pigments, dyes, electronics, cosmetics and personal care products. Consequently, humans are more exposed to zinc oxide nanoparticles via various routes such as dermal penetration, inhalational, oral and intravenous routes. In the last few years, the use of zinc oxide nanoparticles became controversial. Although zinc oxide nanoparticles can pass easily through the cell membrane and interact with cellular macromolecules leading to therapeutic effects on some organs, they were found to exert oxidative stress causing cytotoxic effects on other organs [3Espanani HR, Fazilati M, Sadeghi L, Yousefi BV, Bakhshiani S, Amraie E. Investigation the zinc oxide nanoparticle’s effect on sex hormones and cholesterol in rat. Int Res J Biol Sci 2013; 2(8): 54-8.].

1.1. Therapeutic Benefits of Zinc Oxide Nanoparticles

Nanomedicine is considered a new trend in the world. It is concerned with the biomedical application of nanotechnology in the early diagnosis and treatment of diseases. In recent years, many types of research tried to use the unique properties of nanoparticles; especially zinc oxide nanoparticles in the treatment of some diseases [4McNeil SE. Nanoparticle therapeutics: a personal perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009; 1(3): 264-71.
[http://dx.doi.org/10.1002/wnan.6] [PMID: 20049796]
]. Zinc oxide nanoparticles have bioavailability, biocompatibility, and high solubility. Therefore, they can mimic the biomolecules' activity, and can localize in many body systems wherein biomolecules can regulate the cellular cycle, and maintain cellular homoeostasis [5Vizirianakis IS. Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes. Nanomedicine (Lond) 2011; 7(1): 11-7.
[http://dx.doi.org/10.1016/j.nano.2010.11.002] [PMID: 21094279]
]. In the last decades, chemotherapy, radiation therapy, and surgery were the primary choices for cancer treatment, but they had many adverse effects due to their non-selective effects on the cells; as they might affect normal cells as well. Therefore, searching for another substitute therapy that has the ability to both destroy cancer cells and overcome the various adverse effects of the traditional cancer therapy has become mandatory [6Gowda R, Jones NR, Banerjee S, Robertson GP. Use of nanotechnology to develop multi-drug inhibitors for cancer therapy. J Nanomed Nanotechnol 2013; 4(6): 184-8.
[http://dx.doi.org/10.4172/2157-7439.1000184] [PMID: 25013742]
].

Zinc oxide nanoparticles were approved by Food and Drug Administration (FDA) as a new and potent anticancer therapy [7Shen C, James SA, de Jonge MD, Turney TW, Wright PF, Feltis BN. Relating cytotoxicity, zinc ions, and reactive oxygen in ZnO nanoparticle-exposed human immune cells. Toxicol Sci 2013; 136(1): 120-30.
[http://dx.doi.org/10.1093/toxsci/kft187] [PMID: 23997113]
]. Zinc oxide nanoparticles can produce selective cytotoxicity towards cancer cells via the induction of disequilibrium of zinc-dependent protein activity, in addition to the production of reactive oxygen species [8Vinardell MP, Mitjans M. Antitumor activities of metal oxide nanoparticles. Nanomaterials (Basel) 2015; 5(2): 1004-21.
[http://dx.doi.org/10.3390/nano5021004] [PMID: 28347048]
]. Rasmussen et al. [9Rasmussen JW, Martinez E, Louka P, Wingett DG. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv 2010; 7(9): 1063-77.
[http://dx.doi.org/10.1517/17425247.2010.502560] [PMID: 20716019]
] emphasized the ability of zinc oxide nanoparticles to kill cancer cells through the induction of oxidative stress in the cancerous cells. Furthermore, zinc is involved in all cellular protecting processes against cancer through the activation of DNA repair, and hence preventing both apoptosis and cancer cell growth [10Ho E. Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem 2004; 15(10): 572-8.
[http://dx.doi.org/10.1016/j.jnutbio.2004.07.005] [PMID: 15542347]
].

Zinc channels create a balance between cell survival and cell death via controlling the free and intracellular zinc movements [11Dhawan DK, Chadha VD. Zinc: A promising agent in dietary chemoprevention of cancer. Indian J Med Res 2010; 132: 676-82.
[PMID: 21245614]
]. Zinc also plays an important role to maintain the tumor suppressor gene p53 activity that regulates apoptosis activity [12Ng KW, Khoo SP, Heng BC, et al. The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticles. Biomaterials 2011; 32(32): 8218-25.
[http://dx.doi.org/10.1016/j.biomaterials.2011.07.036] [PMID: 21807406]
]. Moreover, zinc can also help in the activation of the caspase-6 enzyme which is responsible for apoptosis. Therefore, zinc deficiency causes DNA damage and p53 disruption, resulting in the loss of DNA integrity and the potential for increased cancer risk. Hence, zinc oxide nanoparticles are considered potent therapy for many cancers [13Costello LC, Franklin RB, Feng P, Tan M, Bagasra O. Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States). Cancer Causes Control 2005; 16(8): 901-15.
[http://dx.doi.org/10.1007/s10552-005-2367-y] [PMID: 16132800]
].

Many published articles have mentioned that zinc oxide nanoparticles had more than 30 times selective cytotoxicity towards cancer cells compared to healthy cells, and that they could kill cancer cells selectively in vitro and vivo via inferring the selective localization [14Taccola L, Raffa V, Riggio C, et al. Zinc oxide nanoparticles as selective killers of proliferating cells. Int J Nanomedicine 2011; 6: 1129-40.
[PMID: 21698081]
-16Ostrovsky S, Kazimirsky G, Gedanken A, Brodie C. Selective cytotoxic effect of ZnO nanoparticles on glioma cells. Nano Res 2009; 2(11): 882-90.
[http://dx.doi.org/10.1007/s12274-009-9089-5]
]. Zinc oxide nanoparticles were characterized by their enhanced permeation, and by their retention inside the tumor cells. The small size and the surface properties of zinc oxide nanoparticles enabled them to diffuse easily through the blood vessels towards the tumor cells, and to be localized inside these cells specifically, and hence act on them [17Akhtar MJ, Ahamed M, Kumar S, Khan MM, Ahmad J, Alrokayan SA. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine 2012; 7: 845-57.
[PMID: 22393286]
]. Moreover, as zinc oxide nanoparticles show positive charges in the physiological conditions; such as in tissue fluid or in blood, while the cancerous cells have negatively charged phospholipids on their outer membranes, an electrostatic attraction occurs between zinc oxide nanoparticles and the cancerous cells [18Thurber A, Wingett DG, Rasmussen JW, et al. Improving the selective cancer killing ability of ZnO nanoparticles using Fe doping. Nanotoxicology 2012; 6(4): 440-52.
[http://dx.doi.org/10.3109/17435390.2011.587031] [PMID: 21635174]
, 19Degen A, Kosec M. Effect of pH and impurities on the surface charge of zinc oxide in aqueous solution. J Eur Ceram Soc 2000; 20(6): 667-73.
[http://dx.doi.org/10.1016/S0955-2219(99)00203-4]
]. Bisht and Rayamajhi [20Bisht G, Rayamajhi S. ZnO Nanoparticles: A Promising Anticancer Agent. Nanobiomedicine (Rij) 2016; 3: 9.
[http://dx.doi.org/10.5772/63437] [PMID: 29942384]
] reported that zinc oxide nanoparticles have shown anti-proliferative effects, and that zinc nanoparticles succeeded to treat a human gastric adenocarcinoma cell line, resulting in a significant inhibition of cellular proliferation. Therefore, Bisht and Rayamajhi supported the use of zinc oxide nanoparticles as a promising anticancer agent with fewer side effects in comparison to the traditional anticancer therapy.

Badkoobeh et al. [21Badkoobeh P, Parivar K, Kalantar SM, Hosseini SD, Salabat A. Effect of nano-zinc oxide on doxorubicin- induced oxidative stress and sperm disorders in adult male Wistar rats. Iran J Reprod Med 2013; 11(5): 355-64.
[PMID: 24639766]
] suggested that zinc oxide nanoparticles could be used as a potent antioxidant, and as an effective adjuvant treatment to chemotherapeutic drugs that cause reproductive dysfunction in males. This was based upon the ability of zinc oxide nanoparticles to increase the therapeutic efficacy of doxorubicin, and to reduce doxorubicin gonado-toxic properties. Furthermore, several studies revealed the ability of zinc to ameliorate the oxidative stress and glutathione depletion. Other studies emphasized the ability of zinc to enhance the reproductive function, and reported that zinc was found in high levels in the male reproductive system and in the seminal fluid. Therefore, zinc is thought to play an important role in spermatogenesis process [22Zago MP, Oteiza PI. The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic Biol Med 2001; 31(2): 266-74.
[http://dx.doi.org/10.1016/S0891-5849(01)00583-4] [PMID: 11440839]
]. In the same context, Dawei et al. [23Dawei AI, Zhisheng W, Angu Z. Protective effects of Nano-ZnO on the primary culture mice intestinal epithelial cells in in vitro against oxidative injury. Int J Nanotechnol 2009; 3: 1-6.] indicated that zinc oxide nanoparticles had the ability to increase antioxidant enzymes levels, and to decrease malondialdehyde (MDA) level. Therefore, zinc oxide nanoparticles could protect the cell membrane integrity against oxidative stress damage. On the contrary, Sharma et al. [24Sharma V, Singh P, Pandey AK, Dhawan A. Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutat Res 2012; 745(1-2): 84-91.
[http://dx.doi.org/10.1016/j.mrgentox.2011.12.009] [PMID: 22198329]
] reported that sub-acute oral exposure of zinc oxide nanoparticles could induce oxidative stress, DNA damage, and apoptosis in the liver.

Atef et al. [25Atef HA, Mansour MK, Ibrahim EM, et al. Efficacy of zinc oxide nanoparticles and curcumin in amelioration the toxic effects in aflatoxicated rabbits. Int J Curr Microbiol Appl Sci 2016; 5(12): 795-818.
[http://dx.doi.org/10.20546/ijcmas.2016.512.090]
] showed that low doses of zinc oxide nanoparticles had cytoprotective effects. These particles could improve antioxidant activity, and decrease the levels of free radicals resulting from Aflatoxin B1. Aflatoxin B1 induced detrimental effects on humans as well as on animals eating Aflatoxins contaminated feedstuff. Aflatoxins-induced toxic effects included teratogenic, carcinogenic, mutagenic and immunosuppressive effects. Studies have shown a direct correlation between dietary aflatoxins intake in humans and liver cancer [26Richard JL. Some major mycotoxins and their mycotoxicoses--an overview. Int J Food Microbiol 2007; 119(1-2): 3-10.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2007.07.019] [PMID: 17719115]
]. Therefore, according to Atef et al. [25Atef HA, Mansour MK, Ibrahim EM, et al. Efficacy of zinc oxide nanoparticles and curcumin in amelioration the toxic effects in aflatoxicated rabbits. Int J Curr Microbiol Appl Sci 2016; 5(12): 795-818.
[http://dx.doi.org/10.20546/ijcmas.2016.512.090]
], zinc oxide nanoparticles could protect the hepatic cells from the damaging effect of Aflatoxin B1 through scavenging free radicals [25Atef HA, Mansour MK, Ibrahim EM, et al. Efficacy of zinc oxide nanoparticles and curcumin in amelioration the toxic effects in aflatoxicated rabbits. Int J Curr Microbiol Appl Sci 2016; 5(12): 795-818.
[http://dx.doi.org/10.20546/ijcmas.2016.512.090]
].

Zinc oxide nanoparticles affected the growth of both gram positive and gram negative bacteria; so, they could be considered as potent antibacterial agents. The antibacterial effect of zinc oxide nanoparticles is due to the high sensitivity of the lipid bilayer of bacteria to the reactive oxygen species produced by these nanoparticles [27Pasquet J, Chevalier Y, Couval E, et al. Antimicrobial activity of zinc oxide particles on five micro-organisms of the Challenge Tests related to their physicochemical properties. Int J Pharm 2014; 460(1-2): 92-100.
[http://dx.doi.org/10.1016/j.ijpharm.2013.10.031] [PMID: 24211859]
-29Mielcarz-Skalska L, Smolińska B. Zinc and nano-ZnO – influence on living organisms. Biotechnol Food Sci 2017; 81(2): 93-102.]. Moreover, zinc oxide nanoparticles could also be considered as antifungal agents; because they could completely stop the growth of some types of fungi when administered at high concentrations. However, recent studies show that the impact of zinc oxide nanoparticles on some organisms is not yet sufficiently understood despite their widespread use in biomedicine [29Mielcarz-Skalska L, Smolińska B. Zinc and nano-ZnO – influence on living organisms. Biotechnol Food Sci 2017; 81(2): 93-102.].

In the field of cosmetics, zinc oxide nanoparticles powder is widely used in sunscreens and ointments [30Cross SE, Innes B, Roberts MS, Tsuzuki T, Robertson TA, McCormick P. Human skin penetration of sunscreen nanoparticles: In-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol 2007; 20(3): 148-54.
[http://dx.doi.org/10.1159/000098701] [PMID: 17230054]
]. Zinc oxide nanoparticles are considered as ultraviolet blockers and semiconductor agents because they could absorb and scatter the visible ultraviolet rays. The photocatalytic activity of zinc oxide nanoparticles increases with decreasing their sizes [31Filipe P, Silva JN, Silva R, et al. Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol Physiol 2009; 22(5): 266-75.
[http://dx.doi.org/10.1159/000235554] [PMID: 19690452]
]. Numerous studies on healthy human skin suggested that zinc oxide nanoparticles don't penetrate beyond the stratum corneum when they are used in sunscreens [32Osmond MJ, McCall MJ. Zinc oxide nanoparticles in modern sunscreens: An analysis of potential exposure and hazard. Nanotoxicology 2010; 4(1): 15-41.
[http://dx.doi.org/10.3109/17435390903502028] [PMID: 20795900]
].

Zinc oxide nanoparticles are widely used in dietary supplements. They were found to produce an immunomodulatory effect. Roy et al. reported that zinc oxide nanoparticles increased antigen-specific immune reactions in mice. They enhanced antigen-specific antibodies production in serum, especially immunoglobulin E (IgE) and immunoglobulin G (IgG), and they also could enhance the functionality of T cells. It was also detected that zinc oxide nanoparticles had an adjuvant effect toward Th2 response; increasing the production and activation of cytokines [33Roy R, Kumar S, Verma AK, et al. Zinc oxide nanoparticles provide an adjuvant effect to ovalbumin via a Th2 response in Balb/c mice. Int Immunol 2014; 26(3): 159-72.
[http://dx.doi.org/10.1093/intimm/dxt053] [PMID: 24225181]
].

1.2. Toxicological Hazards of Zinc Oxide Nanoparticles

In recent years, a number of studies have shown the possibility of using zinc oxide nanoparticles as therapeutic agents and as gene carriers. At the same time, many published research studies showed the toxic effects of zinc oxide nanoparticles on some specific organs and cell lines. These toxic effects were attributed to the high solubility of the particles, resulting in cytotoxicity, oxidative stress, and mitochondrial dysfunction. Therefore, an urgent necessity exists to evaluate both the toxicological hazards and the therapeutic benefits for the use of zinc oxide nanoparticles in medicine. Furthermore, it is important to determine if their toxicity is reversible, and if this toxicity depends on the concentration and the time of exposure to the particles [34Condello M, De Berardis B, Ammendolia MG, et al. ZnO nanoparticle tracking from uptake to genotoxic damage in human colon carcinoma cells. Toxicol In Vitro 2016; 35: 169-79.
[http://dx.doi.org/10.1016/j.tiv.2016.06.005] [PMID: 27317967]
].

Inhalation of zinc oxide nanoparticles induced inflammation and fibrosis in the alveolar and tracheobronchial tissues depending on the size and solubility of the particles. Acidic lung fluid resulted in the dissolution of zinc oxide nanoparticles, and consequently increased their concentration leading to pulmonary toxicity [35Cho WS, Duffin R, Howie SE, et al. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol 2011; 8: 27.
[http://dx.doi.org/10.1186/1743-8977-8-27] [PMID: 21896169]
]. Furthermore, zinc oxide nanoparticles induced cytotoxicity in human lung epithelial cells via inducing oxidative stress in a concentration-dependent manner, resulting in DNA damage and apoptosis [36Sahu D, Kannan GM, Vijayaraghavan R, Anand T, Khanum F. Nanosized zinc oxide induces toxicity in human lung cells. ISRN Toxicol 2013; 2013: 316075.
[http://dx.doi.org/10.1155/2013/316075] [PMID: 23997968]
].

Intra-peritoneal injection of zinc oxide nanoparticles was found to cause neurotoxic effects in the form of attenuation of the learning ability and memory according to the study of Han et al. [37Han D, Tian Y, Zhang T, Ren G, Yang Z. Nano-zinc oxide damages spatial cognition capability via over-enhanced long-term potentiation in hippocampus of Wistar rats. Int J Nanomedicine 2011; 6: 1453-61.
[PMID: 21796247]
]. Elshama et al. [38Elshama SS, Osman HEH, El-Kenawy AE. Histopathological study of zinc oxide nanoparticle-induced neurotoxicity in rats. Curr Top Toxicol J 2017; 13: 95-103.] found that the prolonged use of zinc oxide nanoparticles via intra-peritoneal route induced histopathological and ultrastructural changes in the brains and spinal cords of rats, depending on the dose, and based on reactive oxygen species generation.

Moreover, Li et al. [39Li CH, Shen CC, Cheng YW, et al. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology 2012; 6(7): 746-56.
[http://dx.doi.org/10.3109/17435390.2011.620717] [PMID: 21950449]
] reported that both intraperitoneal and oral administration of zinc oxide nanoparticles led to systemic distribution and toxic accumulation of the particles in the liver, spleen, kidney, and lung; which were the target organs where the toxic manifestations of zinc oxide nanoparticle have appeared. In male rats, zinc oxide nanoparticles elevated liver enzymes, and led to harmful effects on the body metabolism [40Fazilati M. Investigation toxicity properties of zinc oxide nanoparticles on liver enzymes in male rat. Eur J Exp Biol 2013; 3(1): 97-103.]. In the same context, Soheili et al. [41Soheili S, Moradhaseli S, Shokouhian A, Ghorbani M. Histopathological effects of ZnO nanoparticles on liver and heart tissues in wistar rats. Adv Biores 2013; 4(2): 83-8.] reported that the administration of zinc oxide nanoparticles increased significantly all liver enzymes (e.g. aspartate transaminase “AST”, alanine transaminase “ALT”, alkaline phosphatase “ALP” and lactate dehydrogenase “LDH”) in a dose-dependent manner. Furthermore, the authors reported an increase in the blood glucose level, suggesting the defective effects of zinc oxide nanoparticles on the pancreatic cells. Administration of zinc oxide nanoparticles was also found to induce severe anemia and significant histopathological changes on the livers and hearts of rats. The histopathological changes were in the form of hyaline degeneration of the cardiac muscle and focal hemorrhages associated with hepatic apoptosis. Esmaeilloua et al. [42Esmaeillou M, Moharamnejad M, Hsankhani R, Tehrani AA, Maadi H. Toxicity of ZnO nanoparticles in healthy adult mice. Environ Toxicol Pharmacol 2013; 35(1): 67-71.
[http://dx.doi.org/10.1016/j.etap.2012.11.003] [PMID: 23262039]
] demonstrated that zinc oxide nanoparticles had severe oxidative toxic effects on kidney, lung, and liver. The effects were dependent on the physicochemical properties of nanoparticles such as the specific surface area and the nanoparticle size.

In addition, Ko et al. [43Ko JW, Hong ET, Lee IC, et al. Evaluation of 2-week repeated oral dose toxicity of 100 nm zinc oxide nanoparticles in rats. Lab Anim Res 2015; 31(3): 139-47.
[http://dx.doi.org/10.5625/lar.2015.31.3.139] [PMID: 26472967]
] reported that zinc oxide nanoparticles adversely altered the hematological indices such as hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelets, and white blood cells (total and differential). They also reported histopathological changes in the spleen, stomach, and pancreas associated with zinc oxide nanoparticles administration. In the same context, Seoka et al. [44Seok SH, Cho WS, Park JS, et al. Rat pancreatitis produced by 13-week administration of zinc oxide nanoparticles: Biopersistence of nanoparticles and possible solutions. J Appl Toxicol 2013; 33(10): 1089-96.
[http://dx.doi.org/10.1002/jat.2862] [PMID: 23408656]
] showed that oral intake of high dose zinc oxide nanoparticles led to pancreatitis and anemia.

Kim et al. [45Kim YR, Park JI, Lee EJ, et al. Toxicity of 100 nm zinc oxide nanoparticles: A report of 90-day repeated oral administration in Sprague Dawley rats. Int J Nanomedicine 2014; 9(2)(Suppl. 2): 109-26.
[PMID: 25565830]
] showed that the oral administration of different doses of 100 nm zinc oxide nanoparticles with different surface charges and for a prolonged period induced significant histopathological changes, such as squamous and glandular cell hyperplasia in the stomach, acinar cell apoptosis in the pancreas, retinal atrophy, and suppurative inflammation in the prostate. They also detected disturbances in most hematological indices, and in other biochemical parameters such as blood urea nitrogen, blood glucose and calcium, albumin, and alkaline phosphatase. The previously reported toxic effects were observed at doses greater than 125 mg/kg, while the No Observed Adverse Effect Level (NOAEL) was 31.25 mg/kg.

Sub-chronic use of zinc oxide nanoparticles was found to induce toxic manifestations in the lymphatic system and in the blood cell count depending on the administered dose. The nanoparticles induced a decrease in the total blood cell count (white blood cells, red blood cells, and platelets), a disturbance in the differential white blood cell count, and produced histopathological and ultrastructural changes in thymus, spleen and lymph nodes in rats [46Elshama SS, Salem RR, Osman HEH, El-Kenawy AE. Toxic effect of sub-chronic use of zinc oxide nanoparticles on the lymphatic system of adult albino rats. Curr Top Toxicol J 2017; 13: 127-37.].

Reza et al. [47Reza EH, Mohammad F, Leila S, Vahid YB, Somayeh B, Esmail A. Investigation the Zinc Oxide Nanoparticle’s Effect on Sex Hormones and Cholesterol in Rat. Int Res J Biol Sci 2013; 2(8): 54-8.] conducted a study to investigate the deleterious effects of treating rats with different doses of zinc oxide nanoparticles on Thyroid Stimulating Hormone (TSH), Follicular Stimulating Hormone (FSH) and Luteinizing Hormone (LH) levels, and on cholesterol level in the blood. The authors detected a decrease in FSH level and an increase in TSH level; however, they found an increase in the cholesterol level. The induced effects on rats were associated with the administration of high doses only.

Although available data about the effects of zinc oxide nanoparticles on reproduction and on fetal development are not enough so far, Hong et al. [48Hong JS, Park MK, Kim MS, et al. Prenatal development toxicity study of zinc oxide nanoparticles in rats. Int J Nanomedicine 2014; 9(2)(Suppl. 2): 159-71.
[PMID: 25565834]
] reported that the administration of repeated oral doses of zinc oxide nanoparticles in rats during pregnancy and for short periods of time -not exceeding 15 days- led to maternal and developmental toxicity.

CONCLUSION

Widespread application of zinc oxide nanoparticles in biomedicine attracts wide attention to assess their therapeutic benefits compared to their expected toxicological hazards. Zinc oxide nanoparticles have many therapeutic effects, where they may have antibacterial, anticancer, immunomodulatory, sunscreen and antioxidant effects, or they may be used as an adjuvant treatment to chemotherapeutic drugs to alleviate their toxic effects. Systemic distribution of zinc oxide nanoparticles may lead to toxic manifestations in different body organs and systems, based on their concentration, the administered dose, the route of administration, and on the time of exposure to them. Therefore, Zinc oxide nanoparticles can affect liver, spleen, kidney, stomach, pancreas, heart, lung, neurological system, lymphatic system and hematological indices. They can also affect sex hormones levels and fetal development.

RECOMMENDATION

Further studies need to be done in the future to verify the therapeutic efficacy of zinc oxide nanoparticles, along with the assessment of their toxicological hazards in order to determine the risk benefit ratio of their use in medicine.

CONSENT FOR PUBLICATION

Not applicable.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

ACKNOWLDEGEMENTS

Declared none.

REFERENCES

[1] Handy RD, von der Kammer F, Lead JR, Hassellöv M, Owen R, Crane M. The ecotoxicology and chemistry of manufactured nanoparticles. Ecotoxicology 2008; 17(4): 287-314.
[http://dx.doi.org/10.1007/s10646-008-0199-8] [PMID: 18351458]
[2] Kao YY, Chen YC, Cheng TJ, Chiung YM, Liu PS. Zinc oxide nanoparticles interfere with zinc ion homeostasis to cause cytotoxicity. Toxicol Sci 2012; 125(2): 462-72.
[http://dx.doi.org/10.1093/toxsci/kfr319] [PMID: 22112499]
[3] Espanani HR, Fazilati M, Sadeghi L, Yousefi BV, Bakhshiani S, Amraie E. Investigation the zinc oxide nanoparticle’s effect on sex hormones and cholesterol in rat. Int Res J Biol Sci 2013; 2(8): 54-8.
[4] McNeil SE. Nanoparticle therapeutics: a personal perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009; 1(3): 264-71.
[http://dx.doi.org/10.1002/wnan.6] [PMID: 20049796]
[5] Vizirianakis IS. Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes. Nanomedicine (Lond) 2011; 7(1): 11-7.
[http://dx.doi.org/10.1016/j.nano.2010.11.002] [PMID: 21094279]
[6] Gowda R, Jones NR, Banerjee S, Robertson GP. Use of nanotechnology to develop multi-drug inhibitors for cancer therapy. J Nanomed Nanotechnol 2013; 4(6): 184-8.
[http://dx.doi.org/10.4172/2157-7439.1000184] [PMID: 25013742]
[7] Shen C, James SA, de Jonge MD, Turney TW, Wright PF, Feltis BN. Relating cytotoxicity, zinc ions, and reactive oxygen in ZnO nanoparticle-exposed human immune cells. Toxicol Sci 2013; 136(1): 120-30.
[http://dx.doi.org/10.1093/toxsci/kft187] [PMID: 23997113]
[8] Vinardell MP, Mitjans M. Antitumor activities of metal oxide nanoparticles. Nanomaterials (Basel) 2015; 5(2): 1004-21.
[http://dx.doi.org/10.3390/nano5021004] [PMID: 28347048]
[9] Rasmussen JW, Martinez E, Louka P, Wingett DG. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv 2010; 7(9): 1063-77.
[http://dx.doi.org/10.1517/17425247.2010.502560] [PMID: 20716019]
[10] Ho E. Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem 2004; 15(10): 572-8.
[http://dx.doi.org/10.1016/j.jnutbio.2004.07.005] [PMID: 15542347]
[11] Dhawan DK, Chadha VD. Zinc: A promising agent in dietary chemoprevention of cancer. Indian J Med Res 2010; 132: 676-82.
[PMID: 21245614]
[12] Ng KW, Khoo SP, Heng BC, et al. The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticles. Biomaterials 2011; 32(32): 8218-25.
[http://dx.doi.org/10.1016/j.biomaterials.2011.07.036] [PMID: 21807406]
[13] Costello LC, Franklin RB, Feng P, Tan M, Bagasra O. Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States). Cancer Causes Control 2005; 16(8): 901-15.
[http://dx.doi.org/10.1007/s10552-005-2367-y] [PMID: 16132800]
[14] Taccola L, Raffa V, Riggio C, et al. Zinc oxide nanoparticles as selective killers of proliferating cells. Int J Nanomedicine 2011; 6: 1129-40.
[PMID: 21698081]
[15] Thurber A, Wingett DG, Rasmussen JW, et al. Improving the selective cancer killing ability of ZnO nanoparticles using Fe doping. Nanotoxicology 2012; 6(4): 440-52.
[http://dx.doi.org/10.3109/17435390.2011.587031] [PMID: 21635174]
[16] Ostrovsky S, Kazimirsky G, Gedanken A, Brodie C. Selective cytotoxic effect of ZnO nanoparticles on glioma cells. Nano Res 2009; 2(11): 882-90.
[http://dx.doi.org/10.1007/s12274-009-9089-5]
[17] Akhtar MJ, Ahamed M, Kumar S, Khan MM, Ahmad J, Alrokayan SA. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine 2012; 7: 845-57.
[PMID: 22393286]
[18] Thurber A, Wingett DG, Rasmussen JW, et al. Improving the selective cancer killing ability of ZnO nanoparticles using Fe doping. Nanotoxicology 2012; 6(4): 440-52.
[http://dx.doi.org/10.3109/17435390.2011.587031] [PMID: 21635174]
[19] Degen A, Kosec M. Effect of pH and impurities on the surface charge of zinc oxide in aqueous solution. J Eur Ceram Soc 2000; 20(6): 667-73.
[http://dx.doi.org/10.1016/S0955-2219(99)00203-4]
[20] Bisht G, Rayamajhi S. ZnO Nanoparticles: A Promising Anticancer Agent. Nanobiomedicine (Rij) 2016; 3: 9.
[http://dx.doi.org/10.5772/63437] [PMID: 29942384]
[21] Badkoobeh P, Parivar K, Kalantar SM, Hosseini SD, Salabat A. Effect of nano-zinc oxide on doxorubicin- induced oxidative stress and sperm disorders in adult male Wistar rats. Iran J Reprod Med 2013; 11(5): 355-64.
[PMID: 24639766]
[22] Zago MP, Oteiza PI. The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic Biol Med 2001; 31(2): 266-74.
[http://dx.doi.org/10.1016/S0891-5849(01)00583-4] [PMID: 11440839]
[23] Dawei AI, Zhisheng W, Angu Z. Protective effects of Nano-ZnO on the primary culture mice intestinal epithelial cells in in vitro against oxidative injury. Int J Nanotechnol 2009; 3: 1-6.
[24] Sharma V, Singh P, Pandey AK, Dhawan A. Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutat Res 2012; 745(1-2): 84-91.
[http://dx.doi.org/10.1016/j.mrgentox.2011.12.009] [PMID: 22198329]
[25] Atef HA, Mansour MK, Ibrahim EM, et al. Efficacy of zinc oxide nanoparticles and curcumin in amelioration the toxic effects in aflatoxicated rabbits. Int J Curr Microbiol Appl Sci 2016; 5(12): 795-818.
[http://dx.doi.org/10.20546/ijcmas.2016.512.090]
[26] Richard JL. Some major mycotoxins and their mycotoxicoses--an overview. Int J Food Microbiol 2007; 119(1-2): 3-10.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2007.07.019] [PMID: 17719115]
[27] Pasquet J, Chevalier Y, Couval E, et al. Antimicrobial activity of zinc oxide particles on five micro-organisms of the Challenge Tests related to their physicochemical properties. Int J Pharm 2014; 460(1-2): 92-100.
[http://dx.doi.org/10.1016/j.ijpharm.2013.10.031] [PMID: 24211859]
[28] Applerot BG, Lipovsky A, Dror R, et al. Enhanced antibacterial activity of nanocrystalline ZnO due to increased ROS mediated cell injury. Adv Funct Mater 2009; 52900: 842-52.
[http://dx.doi.org/10.1002/adfm.200801081]
[29] Mielcarz-Skalska L, Smolińska B. Zinc and nano-ZnO – influence on living organisms. Biotechnol Food Sci 2017; 81(2): 93-102.
[30] Cross SE, Innes B, Roberts MS, Tsuzuki T, Robertson TA, McCormick P. Human skin penetration of sunscreen nanoparticles: In-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol 2007; 20(3): 148-54.
[http://dx.doi.org/10.1159/000098701] [PMID: 17230054]
[31] Filipe P, Silva JN, Silva R, et al. Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol Physiol 2009; 22(5): 266-75.
[http://dx.doi.org/10.1159/000235554] [PMID: 19690452]
[32] Osmond MJ, McCall MJ. Zinc oxide nanoparticles in modern sunscreens: An analysis of potential exposure and hazard. Nanotoxicology 2010; 4(1): 15-41.
[http://dx.doi.org/10.3109/17435390903502028] [PMID: 20795900]
[33] Roy R, Kumar S, Verma AK, et al. Zinc oxide nanoparticles provide an adjuvant effect to ovalbumin via a Th2 response in Balb/c mice. Int Immunol 2014; 26(3): 159-72.
[http://dx.doi.org/10.1093/intimm/dxt053] [PMID: 24225181]
[34] Condello M, De Berardis B, Ammendolia MG, et al. ZnO nanoparticle tracking from uptake to genotoxic damage in human colon carcinoma cells. Toxicol In Vitro 2016; 35: 169-79.
[http://dx.doi.org/10.1016/j.tiv.2016.06.005] [PMID: 27317967]
[35] Cho WS, Duffin R, Howie SE, et al. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol 2011; 8: 27.
[http://dx.doi.org/10.1186/1743-8977-8-27] [PMID: 21896169]
[36] Sahu D, Kannan GM, Vijayaraghavan R, Anand T, Khanum F. Nanosized zinc oxide induces toxicity in human lung cells. ISRN Toxicol 2013; 2013: 316075.
[http://dx.doi.org/10.1155/2013/316075] [PMID: 23997968]
[37] Han D, Tian Y, Zhang T, Ren G, Yang Z. Nano-zinc oxide damages spatial cognition capability via over-enhanced long-term potentiation in hippocampus of Wistar rats. Int J Nanomedicine 2011; 6: 1453-61.
[PMID: 21796247]
[38] Elshama SS, Osman HEH, El-Kenawy AE. Histopathological study of zinc oxide nanoparticle-induced neurotoxicity in rats. Curr Top Toxicol J 2017; 13: 95-103.
[39] Li CH, Shen CC, Cheng YW, et al. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology 2012; 6(7): 746-56.
[http://dx.doi.org/10.3109/17435390.2011.620717] [PMID: 21950449]
[40] Fazilati M. Investigation toxicity properties of zinc oxide nanoparticles on liver enzymes in male rat. Eur J Exp Biol 2013; 3(1): 97-103.
[41] Soheili S, Moradhaseli S, Shokouhian A, Ghorbani M. Histopathological effects of ZnO nanoparticles on liver and heart tissues in wistar rats. Adv Biores 2013; 4(2): 83-8.
[42] Esmaeillou M, Moharamnejad M, Hsankhani R, Tehrani AA, Maadi H. Toxicity of ZnO nanoparticles in healthy adult mice. Environ Toxicol Pharmacol 2013; 35(1): 67-71.
[http://dx.doi.org/10.1016/j.etap.2012.11.003] [PMID: 23262039]
[43] Ko JW, Hong ET, Lee IC, et al. Evaluation of 2-week repeated oral dose toxicity of 100 nm zinc oxide nanoparticles in rats. Lab Anim Res 2015; 31(3): 139-47.
[http://dx.doi.org/10.5625/lar.2015.31.3.139] [PMID: 26472967]
[44] Seok SH, Cho WS, Park JS, et al. Rat pancreatitis produced by 13-week administration of zinc oxide nanoparticles: Biopersistence of nanoparticles and possible solutions. J Appl Toxicol 2013; 33(10): 1089-96.
[http://dx.doi.org/10.1002/jat.2862] [PMID: 23408656]
[45] Kim YR, Park JI, Lee EJ, et al. Toxicity of 100 nm zinc oxide nanoparticles: A report of 90-day repeated oral administration in Sprague Dawley rats. Int J Nanomedicine 2014; 9(2)(Suppl. 2): 109-26.
[PMID: 25565830]
[46] Elshama SS, Salem RR, Osman HEH, El-Kenawy AE. Toxic effect of sub-chronic use of zinc oxide nanoparticles on the lymphatic system of adult albino rats. Curr Top Toxicol J 2017; 13: 127-37.
[47] Reza EH, Mohammad F, Leila S, Vahid YB, Somayeh B, Esmail A. Investigation the Zinc Oxide Nanoparticle’s Effect on Sex Hormones and Cholesterol in Rat. Int Res J Biol Sci 2013; 2(8): 54-8.
[48] Hong JS, Park MK, Kim MS, et al. Prenatal development toxicity study of zinc oxide nanoparticles in rats. Int J Nanomedicine 2014; 9(2)(Suppl. 2): 159-71.
[PMID: 25565834]

Endorsements



"Open access will revolutionize 21st century knowledge work and accelerate the diffusion of ideas and evidence that support just in time learning and the evolution of thinking in a number of disciplines."


Daniel Pesut
(Indiana University School of Nursing, USA)

"It is important that students and researchers from all over the world can have easy access to relevant, high-standard and timely scientific information. This is exactly what Open Access Journals provide and this is the reason why I support this endeavor."


Jacques Descotes
(Centre Antipoison-Centre de Pharmacovigilance, France)

"Publishing research articles is the key for future scientific progress. Open Access publishing is therefore of utmost importance for wider dissemination of information, and will help serving the best interest of the scientific community."


Patrice Talaga
(UCB S.A., Belgium)

"Open access journals are a novel concept in the medical literature. They offer accessible information to a wide variety of individuals, including physicians, medical students, clinical investigators, and the general public. They are an outstanding source of medical and scientific information."


Jeffrey M. Weinberg
(St. Luke's-Roosevelt Hospital Center, USA)

"Open access journals are extremely useful for graduate students, investigators and all other interested persons to read important scientific articles and subscribe scientific journals. Indeed, the research articles span a wide range of area and of high quality. This is specially a must for researchers belonging to institutions with limited library facility and funding to subscribe scientific journals."


Debomoy K. Lahiri
(Indiana University School of Medicine, USA)

"Open access journals represent a major break-through in publishing. They provide easy access to the latest research on a wide variety of issues. Relevant and timely articles are made available in a fraction of the time taken by more conventional publishers. Articles are of uniformly high quality and written by the world's leading authorities."


Robert Looney
(Naval Postgraduate School, USA)

"Open access journals have transformed the way scientific data is published and disseminated: particularly, whilst ensuring a high quality standard and transparency in the editorial process, they have increased the access to the scientific literature by those researchers that have limited library support or that are working on small budgets."


Richard Reithinger
(Westat, USA)

"Not only do open access journals greatly improve the access to high quality information for scientists in the developing world, it also provides extra exposure for our papers."


J. Ferwerda
(University of Oxford, UK)

"Open Access 'Chemistry' Journals allow the dissemination of knowledge at your finger tips without paying for the scientific content."


Sean L. Kitson
(Almac Sciences, Northern Ireland)

"In principle, all scientific journals should have open access, as should be science itself. Open access journals are very helpful for students, researchers and the general public including people from institutions which do not have library or cannot afford to subscribe scientific journals. The articles are high standard and cover a wide area."


Hubert Wolterbeek
(Delft University of Technology, The Netherlands)

"The widest possible diffusion of information is critical for the advancement of science. In this perspective, open access journals are instrumental in fostering researches and achievements."


Alessandro Laviano
(Sapienza - University of Rome, Italy)

"Open access journals are very useful for all scientists as they can have quick information in the different fields of science."


Philippe Hernigou
(Paris University, France)

"There are many scientists who can not afford the rather expensive subscriptions to scientific journals. Open access journals offer a good alternative for free access to good quality scientific information."


Fidel Toldrá
(Instituto de Agroquimica y Tecnologia de Alimentos, Spain)

"Open access journals have become a fundamental tool for students, researchers, patients and the general public. Many people from institutions which do not have library or cannot afford to subscribe scientific journals benefit of them on a daily basis. The articles are among the best and cover most scientific areas."


M. Bendandi
(University Clinic of Navarre, Spain)

"These journals provide researchers with a platform for rapid, open access scientific communication. The articles are of high quality and broad scope."


Peter Chiba
(University of Vienna, Austria)

"Open access journals are probably one of the most important contributions to promote and diffuse science worldwide."


Jaime Sampaio
(University of Trás-os-Montes e Alto Douro, Portugal)

"Open access journals make up a new and rather revolutionary way to scientific publication. This option opens several quite interesting possibilities to disseminate openly and freely new knowledge and even to facilitate interpersonal communication among scientists."


Eduardo A. Castro
(INIFTA, Argentina)

"Open access journals are freely available online throughout the world, for you to read, download, copy, distribute, and use. The articles published in the open access journals are high quality and cover a wide range of fields."


Kenji Hashimoto
(Chiba University, Japan)

"Open Access journals offer an innovative and efficient way of publication for academics and professionals in a wide range of disciplines. The papers published are of high quality after rigorous peer review and they are Indexed in: major international databases. I read Open Access journals to keep abreast of the recent development in my field of study."


Daniel Shek
(Chinese University of Hong Kong, Hong Kong)

"It is a modern trend for publishers to establish open access journals. Researchers, faculty members, and students will be greatly benefited by the new journals of Bentham Science Publishers Ltd. in this category."


Jih Ru Hwu
(National Central University, Taiwan)


Browse Contents




Webmaster Contact: info@benthamopen.net
Copyright © 2019 Bentham Open